Symptom questionnaire administered to all study participants on the day of nasopharyngeal swab (SARS-CoV-2 PCR) that assesses for evidence of current infection. The questionnaire is then repeated on a daily basis for the subsequent 7 days. The questionnaire will help to distinguish between symptomatic and asymptomatic participants.